Literature DB >> 16585021

High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma.

Fabrizio Marcucci1, Alfonso Mele, Enea Spada, Angela Candido, Elvira Bianco, Alessandro Pulsoni, Paola Chionne, Elisabetta Madonna, Rodolfo Cotichini, Anna Barbui, Amalia De Renzo, Fausto Dore, Emilio Iannitto, Vincenzo Liso, Bruno Martino, Marco Montanaro, Livio Pagano, Pellegrino Musto, Maria Rapicetta.   

Abstract

In this hospital-based, multicenter case-control study we investigated the prevalence of hepatitis B virus (HBV)-related markers and HBV/hepatitis C virus (HCV) co-infection among B-cell non-Hodgkin's lymphoma (B-NHL) cases and controls. Four hundred newly diagnosed B-NHL cases and 392 controls from other departments of the same hospitals were studied. The prevalence of positivity for hepatitis B surface antigen (HBsAg) was 8.5% among B-NHL cases and 2.8% among controls (adjusted odds ratio, 3.67; 95% confidence interval, 1.75-7.66). HBV/HCV co-infection was found in four cases, but in no controls. The finding of a positive association between HBV infection and B-NHL raises the possibility that HBV may play an etiologic role in the induction of B-NHL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585021

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  40 in total

1.  Prevalence of hepatitis B virus in primary central nervous system lymphoma.

Authors:  G Faivre; V Thibault; M L Tanguy; V Leblond; S Choquet; C Soussain; A Gonzalez-Aguilar; M Sierra del Rio; C Houillier; K Hoang-Xuan; A Idbaih
Journal:  J Neurooncol       Date:  2015-08-14       Impact factor: 4.130

Review 2.  Hepatitis viruses and non-Hodgkin's lymphoma: A review.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Rudragoud S Policegoudra; Hemant K Gogoi; Lokendra Singh
Journal:  World J Virol       Date:  2012-12-12

3.  Risk of malignant lymphoma following viral hepatitis infection.

Authors:  Pierluigi Cocco; Giovanna Piras; Maria Monne; Antonella Uras; Attilio Gabbas; Maria G Ennas; Angelo Palmas; Marco Murineddu; Stefania Collu; Massimo Melis; Marco Rais; Pierfelice Todde; Maria G Cabras; Emanuele Angelucci; Giovannino Massarelli; Alexandra Nieters
Journal:  Int J Hematol       Date:  2008-05-01       Impact factor: 2.490

4.  Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-06-14       Impact factor: 6.047

5.  Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B.

Authors:  Geffen Kleinstern; Rania Abu Seir; Riki Perlman; Ziad Abdeen; Areej Khatib; Husein Elyan; Eldad J Dann; Meirav Kedmi; Martin Ellis; Arnon Nagler; Gail Amir; Dina Ben Yehuda; Rifaat Safadi; Ora Paltiel
Journal:  Haematologica       Date:  2016-04-21       Impact factor: 9.941

6.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

7.  Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.

Authors:  Weicheng Ren; Xiaofei Ye; Hong Su; Wei Li; Dongbing Liu; Mohammad Pirmoradian; Xianhuo Wang; Bo Zhang; Qiang Zhang; Longyun Chen; Man Nie; Yao Liu; Bin Meng; Huiqiang Huang; Wenqi Jiang; Yixin Zeng; Wenyu Li; Kui Wu; Yong Hou; Klas G Wiman; Zhiming Li; Huilai Zhang; Roujun Peng; Shida Zhu; Qiang Pan-Hammarström
Journal:  Blood       Date:  2018-03-15       Impact factor: 22.113

8.  Hematopoietic malignancies associated with viral and alcoholic hepatitis.

Authors:  Lesley A Anderson; Ruth Pfeiffer; Joan L Warren; Ola Landgren; Shahinaz Gadalla; Sonja I Berndt; Winnie Ricker; Ruth Parsons; William Wheeler; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10-28       Impact factor: 4.254

9.  Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.

Authors:  D Francisci; F Falcinelli; E Schiaroli; M Capponi; B Belfiori; L Flenghi; F Baldelli
Journal:  Infection       Date:  2009-11-10       Impact factor: 3.553

10.  Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies.

Authors:  Erin Jou; Oleg Gligich; Alvita C Y Chan; Diwakar Mohan; Uriel R Felsen; Sabarish Ayyappan; Henny H Billett; Edwin P Hui; Anthony T C Chan; Radha Raghupathy
Journal:  Ann Hematol       Date:  2016-01-09       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.